Hjem › Leverkreft (hepatocellulært karcinom) › Michigan
Kliniske studier for Leverkreft (hepatocellulært karcinom) i Michigan
20 studier for Leverkreft (hepatocellulært karcinom) søker deltakere på steder i Michigan.
Byer i Michigan
Offisiell studietekst (engelsk)
The Vanguard Study: Testing a New Way to Screen for Cancer
- Henry Ford Cancer Institute-Downriver, Brownstown
- Henry Ford Health Center - Brownstown, Brownstown
- Henry Ford Health Center - Chesterfield, Chesterfield
- og 13 flere
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 45 til 75 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06995898A Study of ZW251 in Participants With Advanced Solid Tumors
- START Midwest, Grand Rapids
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07164313Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #65, Detroit
- Exelixis Clinical Site #13, Detroit
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT05176483National Liver Cancer Screening Trial
- University of Michigan, Ann Arbor
- Henry Ford Health System, Detroit
RekruttererFase 4
Alder 18 til 85 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06084234A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
- Local Institution - 0134, Detroit
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07291076Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
- Karmanos Cancer Institute, Detroit
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT06915753Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
- Henry Ford Health, Detroit
- University of Michigan Health - West, Wyoming
RekruttererObservasjonsstudie
Alder 22 og eldre · Alle kjønn · Oppdatert 11. sep. 2026 · NCT06486454Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- Research Site, Detroit
- Research Site, Grand Rapids
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06921785Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- C S Mott Children's Hospital, Ann Arbor
RekruttererFase 1/2
12 Months – 30 Years · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04851119Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
- Henry Ford Cancer Institute-Downriver, Brownstown
- Henry Ford Medical Center-Fairlane, Dearborn
- Henry Ford Hospital, Detroit
- og 4 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT07166406A Study of MGC026 in Participants With Advanced Solid Tumors
- START Midwest, Grand Rapids
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT06242470Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
- Michigan Cancer Research Consortium NCORP, Ann Arbor
- University of Michigan Comprehensive Cancer Center, Ann Arbor
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 4. aug. 2026 · NCT05168163A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Karmanos Cancer Institute, Detroit
- Karmanos Cancer Institute, Farmington Hills
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 22. jul. 2026 · NCT05208762CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
- University of Michigan, Ann Arbor
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 2. jul. 2026 · NCT06184152A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
- Clinical Trial Site, Ann Arbor
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 17. jun. 2026 · NCT06600321Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Rekrutterer
Alder 18 til 75 · Alle kjønn · Oppdatert 17. jun. 2026 · NCT05486572A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
- University of Michigan Rogel Cancer Center, Ann Arbor
- Barbara Ann Karmanos Cancer Institute, Detroit
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 27. apr. 2026 · NCT05440708A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
- Rogel Comprehensive Cancer Center, Ann Arbor
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 13. mar. 2026 · NCT05901519A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 129, Detroit
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 21. nov. 2025 · NCT05914116SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Ann Arbor
- Massive Bio SYNERGY-AI site, Lansing
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.